Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.79 (
hormone-sensitive lipase
)
2,163
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adipose lipolysis is mediated, in part, via interaction of fatty acid-binding protein (FABP) with
hormone-sensitive lipase
(
HSL
). Mice with reduced FABP content in fat (adipocyte FABP null) exhibit diminished fat cell lipolysis, whereas transgenic mice with increased FABP content in fat (epithelial FABP transgenic) exhibit enhanced lipolysis. To examine the relationship between the binding of FABP to
HSL
and activation of catalytic activity, isothermal titration microcalorimetry as well as kinetic analysis using a variety of FABP isoforms have been employed. In the absence of fatty acids, no FABP-
HSL
association could be demonstrated for any FABP form. However, in the presence of 10 microm oleate, A-FABP and
E-FABP
each bound to
HSL
with high affinity (Kd of 0.5 and 3 nM, respectively) in a approximately 1:1 molar stoichiometry, whereas liver FABP and intestinal FABP did not exhibit any association. To compare binding to catalysis, each FABP isoform was incubated with
HSL
in vitro, and enzymatic activity was assessed. Importantly, each FABP form stimulated
HSL
activity approximately 2-fold using cholesteryl oleate as substrate but exhibited no activation using p-nitrophenyl butyrate. The activation by A-FABP was dependent upon its fatty acid binding properties because a non-fatty acid binding mutant, R126Q, failed to activate
HSL
. These results suggest that binding and activation of
HSL
by FABPs are separate and distinct functions and that
HSL
contains a site for fatty acid binding that allows for FABP association.
...
PMID:Fatty acid-binding protein-hormone-sensitive lipase interaction. Fatty acid dependence on binding. 1312 24